Good News Tuesday: Entrada Therapeutics supports initiatives to help those with Duchenne Muscular Dystrophy

Entrada Therapeutics Inc. a biopharmaceutical company aiming to transform the lives of patients through its new class of medicines, has announced recipients of its inaugural Entrada DREAMS Grant Program.

How CareYaya uses gig-based approach to match college students with caregiving needs

Awry Brewing Co. to open in former V-Grits location on July 13

Work begins to cap I-95 with 11.5-acre Park at Penn’s Landing

Bank of America shares plans for Buffalo branches closed since 2020

Tim Niver’s new deli/bagel venture is on the way

Panthers’ MLS bid scores lead soccer sponsor

Viewpoint: Why Philadelphia should win in the competition for remote workers

Investors eye Heritage Square in Durham for residential, life sciences project after $62M deal

Good News Tuesday: Entrada Therapeutics supports initiatives to help those with Duchenne Muscular Dystrophy

Previous Beverly Hills-based buyer picks up Northside apartments for $7.5M

Next Virginia Tech receives record-tying $50M donation from Richmond's Red Gates Foundation

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Unique $3.5M West Bend property has pool, elevated clubhouse, ‘she shed’ and more: Open House

Planned Parenthood has pop-up clinics for patients seeking gender-affirming care

Southern States Bank, AuburnBank report quarterly growth

First Look: New restaurant to open in Founders Station downtown

4 features senior living consumers look for post-pandemic

Gabler Realty grows with addition of new real estate team

MENU

FirstStar Group

More Stories

These 25 Philadelphia-area stocks took the biggest losses on the way to a bear market